Cargando…
Barriers and Facilitators of Availability of Hydroxyurea for Sickle Cell Disease in Tanzania; A Qualitative Study of Pharmaceutical Manufacturers, Importers, and Regulators
Despite three decades of proven safety and effectiveness of hydroxyurea in modifying sickle cell disease (SCD), its accessibility is limited in Sub-Saharan Africa, which shares 75% of the world’s SCD burden. Therefore, it is time to explore the barriers and facilitators for manufacturing and importa...
Autores principales: | Mlyuka, Hamu J., Kilonzi, Manase, Mutagonda, Ritah F., Chirande, Lulu, Mikomangwa, Wigilya P., Myemba, David T., Sambayi, Godfrey, Mwakawanga, Dorkasi L., Ndunguru, Joyce, Jonathan, Agnes, Makani, Julie, Ruggajo, Paschal, Minja, Irene K., Balandya, Emmanuel, Kamuhabwa, Appolinary A. R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9690851/ https://www.ncbi.nlm.nih.gov/pubmed/36360565 http://dx.doi.org/10.3390/healthcare10112223 |
Ejemplares similares
-
The Effects of Sickle Cell Disease on the Quality of Life: A Focus on the Untold Experiences of Parents in Tanzania
por: Kilonzi, Manase, et al.
Publicado: (2022) -
Nasopharyngeal Carriage and Antibiogram of Pneumococcal and Other Bacterial Pathogens from Children with Sickle Cell Disease in Tanzania
por: Mutagonda, Ritah F, et al.
Publicado: (2022) -
Promoting access of hydroxyurea to sickle cell disease individuals: Time to make it an essential medicine
por: Kilonzi, Manase, et al.
Publicado: (2022) -
Level of knowledge among health care providers on preparation of injectable artesunate for treatment of severe malaria in public health facilities in Tanzania
por: Mikomangwa, Wigilya P., et al.
Publicado: (2019) -
Level of medication self-management capacity among patients on ambulatory care exiting hospital pharmacy at Muhimbili National Hospital, Tanzania: a descriptive cross-sectional study
por: Mlyuka, Hamu, et al.
Publicado: (2019)